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Experimental 
General procedures 
N,N-Dimethylformamide (DMF) was pre-dried over 4 Å molecular sieves prior to distillation.  
Triethylamine was distilled from calcium hydride and stored under nitrogen in an amber bottle. 1H, 13C 
and 31P NMR spectra were recorded on a Bruker Avance 400 NMR spectrometer at 20 °C in CDCl3 or 
DMSO-d6 using tetramethylsilane (TMS) as an internal standard and 85% aq. phosphoric acid as an 
external standard for 31P NMR. Chemical shifts are expressed in parts per million (ppm) relative to the 
reference peak.  
N9-(2-Hydroxyethyl)adenine (4)[1]  
To a stirred solution of adenine (14.9 g, 110 mmol, 1.00 equiv) in distilled N,N-dimethylformamide (80 
mL) at room temperature under nitrogen was added ethylene carbonate (10.0 g, 113 mmol, 1.13 equiv) 
and sodium hydroxide (0.50 g, 12.5 mmol). The reaction mixture heated to reflux and allowed to stir 
until it was evident that the starting material, adenine, had been consumed by TLC (Rf = 0.05 – eluent: 
10% MeOH in CH2Cl2). On cooling, the solvent was removed in vacuo and the off-white/yellow solid 
residues, containing a 9:1 mixture of the N9 and N7 regioisomers by 1H NMR analysis, were 
recrystallized from methanol yielding the title compound as an off-white powder (14.20 g, 75 mmol, 
68%). Spectroscopic data are consistent with those reported in the literature. 
Melting Point (MeOH): 238-239 °C (lit: 238-239 °C) [1] 
1H NMR† (400 MHz, DMSO-d6): 3.40 (1H, bs, OH), 3.74 (2H, t, J = 5.45 Hz, CH2OH), 4.19 (2H, t, J = 5.45 Hz, 
N-CH2), 7.22 (2H, bs, NH2), 8.08 (1H, s, Ar-H), 8.14 (1H, s, Ar-H). 
13C NMR† (75 MHz, DMSO-d6): 45.68 (N-
CH2), 59.21 (CH2-O), 118.62 (ArC), 141.32 (ArC), 149.49 (ArC), 152.22 (ArC), 155.87 (ArC). IR (KBr, cm
-1): 
3311, 3246, 3056, 2930, 2865, 1687, 1607, 1574, 1067, 1018. 
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O,O-Diethyl hydroxymethylphosphonate (10) [2]  
Adapted from Phillion et al. To a stirred suspension of paraformaldehyde (2.22 g, 72 mmol, 1.00 equiv) 
in diethyl phosphite (11) (10.00 g, 72 mmol, 1.00 equiv) was added triethylamine (732 mg, 1.00 mL, 7 
mmol, 0.10 equiv). The resulting suspension was heated to 90 °C and the suspension became clear and 
the mixture began reflux. The reaction was maintained at this temperature for three hours. The product 
was then purified by flash column chromatography (Rf 10 = 0.60, eluent – 100% EtOAC) and was isolated 
as a colourless oil (11.62 g, 70 mmol, 96%).  
1H NMR (400 MHz, CDCl3): 1.35 (6H, t, J = 7.19 Hz, OCH2CH3), 3.91 (2H, dd appears as a triplet, JH-H = JH-P = 
6.30 Hz, HOCH2P), 4.13-4.24 (4H, m, OCH2CH3), 4.81 – 4.86 (1H, m, HOCH2P). 
13C NMR (100 MHz, CDCl3): 
16.35 (d, J = 5.68 Hz, OCH2CH3), 56.87 (d, J = 162.21 Hz, HOCH2P), 62.51 (d, J = 6.76 Hz, OCH2CH3) 
31P 
NMR (175 MHz, CDCl3): 24.52. HRMS (ESI
+): Exact mass calc. C5H14O4P [M+H] = 169.0627; Found = 
169.0630.  
O,O-Diethyl iodomethylphosphonate (7) 
To a stirred solution of tosylate 5 (644 mg, 2 mmol, 1.00 equiv) in acetone (10 mL) was added sodium 
iodide (600 mg, 4 mmol, 2.00 equiv) in a single portion. The resulting suspension was stirred at reflux 
overnight and subsequently allowed to cool. Water (20 mL) was added to the reaction mixture and the 
product was extracted into dichloromethane (20 mL) and washed with 2% sodium thiosulfate (10 mL). 
Drying of the solvent over magnesium sulfate and removal of the solvent in vacuo furnished the title 
compound as a pale yellow oil (485 mg, 1.82 mmol, 91%).  
1H NMR (400 MHz, CDCl3): 1.30 (6H, t, J = 7.20 Hz, OCH2CH3), 2.99 (2H, d, J = 10.37 Hz, ICH2), 4.12 (4H, 
overlapping doublet of quartets appearing as a quintet, JH-P = JH-H = 7.40 Hz, OCH2). 
13C NMR (100 MHz, 
CDCl3): -14.32 (d, JC-P = 155.00 Hz, CH2I), 16.33 (d, JC-P = 5.98 Hz, CH3), 63.34 (d, JC-P = 6.44 Hz, OCH2) 
31P 
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NMR (175 MHz, CDCl3): 20.63. HRMS (ESI
+): Exact mass calc. C7H17IO4P [M+H] = 322.9904; Found = 
322.9909.  
O,O-Diethyl (trifluoromethanesulfonyl)methylphosphonate (8) [3] 
To a stirred solution of diethyl (hydroxyethyl)phosphonate (10, 5.04 g, 30.0 mmol, 1.00 equiv) in 
dichloromethane (100 mL) was added triethylamine (3.60 g, 36.0 mmol, 1.20 equiv). The mixture was 
cooled to −50 °C using a liquid nitrogen/methanol slush bath under nitrogen. Triflic anhydride (10.5 g, 
6.4 mL, 36.0 mmol, 1.20 equiv) was added dropwise to the stirring solution and the reaction mixture 
was allowed to warm slowly to room temperature and was kept at this temperature for two hours. 
Dichloromethane (40 mL) was then added to the reaction mixture before washing with 2 M HCl (20 mL), 
water (20 mL) and brine (20 mL). The organic phase was dried over magnesium sulfate and the solvent 
removed in vacuo to furnish the title compound as a yellow oil (712 mg, 2.40 mmol, 79%).  
1H NMR (400 MHz, CDCl3): 1.39 (6H, t, J = 7.08 Hz, OCH2CH3), 4.25 (H, overlapping dq appearing as a 
quintet, JH-H = JH-P = 7.10 Hz, OCH2H3), 4.63 (2H, d, J = 8.85 Hz, OCH2P). 
13C NMR (100 MHz, CDCl3): 16.23 
(d, JC-P = 5.65 Hz, OCH2CH3), 63.86 (d, JC-P = 6.45 Hz, OCH2CH3), 66.42 (d, JC-P = 168.63 Hz, OCH2P), 118.58 
(quartet, JC-F = 321.10 Hz, F3C-SO2R). 
19F NMR (376 MHz, CDCl3): -74.13. 
31P NMR (175 MHz, CDCl3): 12.19. 
General procedure: Determination of conversion of alcohol 4 to phosphonate 6 using electrophiles 5, 
7 and 8. 
To a stirred suspension of magnesium tert-butoxide (510 mg, 3.00 mmol, 3.00 equiv) in anhydrous N,N-
dimethylformamide (10 mL) was added alcohol 4 (179 mg, 1.00 mmol, 1.00 equiv). The resulting slurry 
was stirred under a nitrogen atmosphere for 45 minutes. Electrophile 5, 7 or 8 (1.50 mmol, 1.50 equiv) 
was then added and the reaction mixture was heated to an internal temperature of ca. 75 °C. The 
reaction was allowed to proceed for 24 hours after which time it was allowed to cool to room 
temperature and the magnesium tert-butoxide was quenched with acetic acid (1.00 mL). Removal of the 
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solvent in vacuo followed by co-distillation with toluene (3 × 30 mL) to remove excess DMF afforded the 
crude reaction mixture as a sticky orange resin which was analysed by 1H and 31P NMR in order to 
determine the conversion to 6. NOTE: Care should be taken at this point to minimise yield loss due to 
losses on transfer. The crude reaction mixture is very sticky and viscous and can be difficult to transfer 
manually, however it is soluble in methanol.  
The crude reaction mixture was then subjected to column chromatography on silica gel (gradient 
elution: 0–10% MeOH in CH2Cl2) in order to determine the yield of 6. NOTE: A wide column should be 
used here as the crude reaction mixture tends to precipitate, blocking the flow of solvent through the 
column, which can lead to a build up of pressure within the column.  
Spectral data for 6 are given below. 
N9-(2-Bromoethyl)adenine (12) 
To a stirred suspension of adenine (3, 1.35 g, 10 mmol, 1.00 equiv) and potassium carbonate (3.21 g, 23 
mmol, 2.30 equiv) in N,N-dimethylformamide (30 mL) was added 1,2-dibromoethane (7.40 g, 3.41 mL, 
40 mmol, 4.00 equiv) in a single portion. The mixture was stirred under a nitrogen atmosphere for 20 
hours after which time the starting material was no longer detectable by TLC and the emergence of a 
new spot (Rf 12 = 0.40; eluent – 10% MeOH in CH2Cl2) was evident. The solvent was removed in vacuo 
and the residue suspended in water before isolation by vacuum filtration. Washing with cold water (20 
mL) and further drying afforded 1.88 g (78%, 7.8 mmol) of the title compound as an orange solid.  
Melting point: 297-299 °C. 1H NMR (400 MHz, DMSO-d6): 3.95 (2H, t, J = 5.97, CH2Br), 4.57 (2H, t, J = 
5.97, CH2N), 7.27 (2H, bs, NH2), 8.15 (1H, s, ArH), 8.19 (1H, s, ArH). 
13C NMR† (100 MHz, DMSO-d6): 31.54 
(CH2Br), 44.61 (CH2N), 118.65 (qArC-NH2), 140.87 (ArCH), 149.44 (qArC), 152.48 (ArCH), 155.96 (qArC). IR 
(KBr, cm-1): 1385, 1357, 1326, 1305, 1246, 1072, 887, 796, 709, 646. HRMS (ESI+): Exact mass calc. for 
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C7H9N5
79Br [M+H]) = 242.0041. Found = 242.0023. Exact mass calc. for C7H9N5
81Br [M+H] = 244.0290. 
Found = 244.0292.  
N9-(2-Iodoethyl)adenine (9) 
To a stirred suspension of sodium iodide (900 mg, 6 mmol, 2.00 equiv) in acetonitrile (20 mL) was added 
bromide 12 (750 mg, 3 mmol, 1.00 equiv). The reaction mixture was heated to reflux and stirred for 48 
hours after which time the starting material was no longer evident by TLC. The solvent was removed in 
vacuo and the resulting slurry was suspended in water (15 mL) and filtered. The filter cake was washed 
with water (2 × 10 mL) and recrystallized from methanol to furnish the title compound (766 mg, 2.44 
mmol, 88%) as an off-white solid. Melting point (MeOH): 220-223 °C (Decomposition).  
1H NMR (400 MHz, DMSO-d6): 3.68 (2H, t, J = 6.48 Hz, CH2CH2I), 4.51 (2H, t, J = 6.48 Hz, CH2CH2I), 7.29 
(2H, bs, NH2), 8.15-8.17 (2 x 1H overlapping singlets, ArH). 
13C NMR (100 MHz, DMSO-d6): 4.30 (CH2CH2I), 
45.13 (CH2CH2I), 118.67 (ArC(NH2)), 140.60 (ArCH), 149.32 (ArC), 152.45 (ArCH), 155.94 (ArC). IR (KBr, 
cm-1): 3332, 3282, 2980, 2912, 1385, 1357, 1326, 1305, 1246, 1072, 512. HRMS (ESI+): Exact mass calc. 
C7H9N5I [M+H] = 289.9903; Found = 289.9897. Anal. Calc.: C, 29.08; H, 2.79; N, 24.23. Found: C, 29.34; H, 
2.81; N, 24.40. 
Reaction of iodide 9 with alcohol 10 to give 6  
To a stirred solution of alcohol 10 (510 mg, 3.00 mmol, 1.00 equiv) in anhydrous DMF (30 mL) was added 
sodium hydride (76 mg, 3.30 mmol, 1.10 equiv) portionwise under a nitrogen atmosphere at room 
temperature. The resulting suspension was allowed to stir for an hour before iodide 9 (870 mg, 3.00 
mmol, 1.00 equiv) was added in a single portion. The reaction was allowed stir overnight for ca. 16 h 
before the addition of ice-water (2 mL). The solvent was removed in vacuo and the yellow residue was 
purified by column chromatography (0–10% MeOH in CH2Cl2) to afford 6 as a foamy white residue (231 
mg, 0.70 mmol, 21%).  
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Melting point (EtOAc): 134-136 °C. (Lit: 135-136 °C) [4] 
1H NMR (400 MHz, DMSO-d6): 1.14 (6H, t, J = 7.08 Hz, OCH2CH3 x 2), 3.84-3.95 (8H, m,  PCH2O, OCH2CH3 
x 2, ArCH2CH2O), 4.33 (2H, t, J = 5.11 Hz, ArCH2CH2O), 7.22 (2H, bs, NH2), 8.08 (1H, s, ArC(8)H), 8.14 (1H, 
s, ArC(2)H). 13C NMR (100 MHz DMSO-d6): 16.13 (d, J = 16.13 Hz, OCH2CH3), 42.33 (ArCH2CH2O), 61.66 (d, 
J = 6.31 Hz, OCH2CH3), 63.67 (d, J = 160.69 Hz, OCH2P), 70.24 (d, J = 11.75 Hz, ArCH2CH2O), 118.53 
(ArC(5)), 141.01 (ArC(8)H), 149.47 (ArC(4)), 152.32 (ArC(2)H), 155.89 (ArC(6)). 31P NMR (100 MHz, DMSO-
d6): 20.88. IR (KBr, cm
-1): 3382, 3322, 2980, 2912, 1385, 1357, 1326, 1305, 1246, 1072. HRMS (ESI+): 
Exact mass calc. for C12H21N5O4P
+ [M+H+] 330.1331; Found 330.1322.  
Also isolated was O,O-diethyl ethoxymethylphosphonate (13) as a pale yellow oil (108 mg, 0.55 mmol, 
37%) as the least polar fraction after column chromatography.  
1H NMR (400 MHz, CDCl3): 1.16 (3H, t, J = 6.84 Hz, CH3CH2OCH2P), 1.28 (6H, t, J = 7.08 Hz, OCH2CH3 x 2), 
3.56 (2H, d, J = 6.84 Hz, CH3CH2OCH2P), 3.71 (2H, d, J = 8.71 Hz, CH3CH2OCH2), 4.11 (4H, overlapping 
doublet of quartets appearing as a quintet, JH-H = JH-P  = 7.26 Hz, OCH2CH3 x 2). 
13C NMR (100 MHz, CDCl3): 
14.90 (CH3CH2OCH2P), 16.57 (d, J = 5.57 Hz, OCH2CH3), 62.40 (d, J = 6.43 Hz, CH3CH2OCH2), 64.64 (d, J = 
167.23 Hz, CH3CH2OCH2P), 69.11 (d, J = 12.47 Hz, OCH2CH3). 
31P NMR (175 MHz, CDCl3): 22.23.  
O,O-Diethyl 2-Chloroethoxymethylphosphonate (19) [5]  
To a two-necked 25 mL round bottom flask, equipped with a distillation condenser and a receiving 
vessel, was added neat triethyl phosphite (7.6 g, 8.00 mL, 48 mmol, 1.00 equiv). The triethyl phosphite 
was heated to an internal temperature of ca. 125–140 °C with stirring. Ether 18 (6.00 g, 48 mmol, 1.00 
equiv) was added dropwise to the flask over approximately 10 minutes. The reaction was allowed to stir 
at this temperature for a further 4 hours, washing the sides of the flask with hexane to ensure complete 
consumption of both starting materials, after which time the reaction was found to be complete by 31P 
NMR analysis.  The title compound was used without further purification (11.03 g, 48 mmol, 100%).  
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1H NMR (400 MHz, CDCl3): 1.29 (6H, t, J = 7.33 Hz, OCH2CH3), 3.58 (2H, t, J = 5.76 Hz, ClCH2CH2O), 3.78-
3.81 (4H, multiplet, ClCH2CH2O and OCH2P), 4.12 (4H, overlapping doublet of quartets appearing as a 
quintet, JH-H = JH-P = 7.33 Hz). 
13C NMR (100 MHz, CDCl3): 15.47 (d, JC-P = 5.68 Hz, OCH2CH3), 41.44 
(ClCH2CH2O), 61.57 (d, JC-P = 6.51 Hz, OCH2CH3), 64.65 (d, JC-P = 164.00 Hz, OCH2P), 72.08 (d, JC-P = 10.43 
Hz, ClCH2CH2O). 
31P NMR (175 MHz, CDCl3): 20.43.  
O,O-Diethyl 2-Iodoethoxymethylphosphonate (14) 
To a stirred suspension of sodium iodide (21.00 g, 140 mmol, 2.00 equiv) in acetone (20 mL) was added 
chloride 19 (16.40 g, 70 mmol, 1.00 equiv) in a single portion. The resulting suspension was heated to 
reflux resulting in a clear yellow solution. The reaction mixture was stirred for 24 hours at this 
temperature during which time the reaction mixture became cloudy. After cooling the resulting 
suspension was filtered and the mother liquor was concentrated in vacuo. The yellow oily residue was 
reconstituted in chloroform (40 mL), washed with 5% sodium thiosulfate (0 mL), dried over magnesium 
sulfate and concentrated in vacuo to furnish the title compound (18.71 g, 58.1 mmol, 83%) as a 
colourless oil which turned slightly yellow on storage.  
1H NMR (400 MHz, CDCl3): 1.20 (6H, t, J = 6.80 Hz, OCH2CH3), 3.14 (2H, t, J = 5.76 Hz, ICH2CH2O), 3.78-
3.81 (4H, multiplet, ClCH2CH2O and OCH2P), 4.12 (4H, overlapping doublet of quartets appearing as a 
quintet, JH-H = JH-P = 7.33 Hz). 
13C NMR (100 MHz, CDCl3): 0.04 (ICH2CH2O), 14.65 (d, JC-P = 5.74 Hz, 
OCH2CH3), 60.71 (d, JC-P = 6.50 Hz, OCH2CH3), 63.07 (d, JC-P = 166.37 Hz, OCH2P), 71.76 (d, JC-P  = 11.24 Hz, 
ICH2CH2O). 
31P NMR (175 MHz, CDCl3): 20.44. HRMS (ESI
+): Exact mass calc. C7H17O4PI [M+H] = 322.9909; 
Found = 322.9915. 
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Alkylation of adenine (3) with 14  
To a stirred solution of iodide 14 (10.00 g, 31.0 mmol, 1.05 equiv) in DMF (100 mL) was added adenine 
(3, 3.05 g, 30 mmol, 1.00 equiv) and potassium carbonate (6.00 g, 45 mmol, 1.50 equiv) in a single 
portion. The reaction was allowed to stir at room temperature for 30 hours until complete consumption 
of adenine was evident by TLC (Rf = 0.00, 10% MeOH in CH2Cl2). The reaction mixture was filtered by 
gravity and the filtrate was concentrated in vacuo to yield a yellow oily residue which was then 
codistilled with toluene (3 × 30 mL) to remove the remaining traces of DMF. Purification of the resulting 
residue by column chromatography (Rf (6) = 0.48; Gradient 0–10% MeOH in CH2Cl2) furnished (6.90 g, 
22.00 mmol, 70%) of the title compound as a colourless foam.  
Spectral data consistent with those reported above. 
Also present in the crude reaction mixture was the N7-regioisomer (17). Based on integration of the 
NCH2 signals in the 
1H NMR spectrum of the crude reaction mixture at 4.33 ppm (6) and 4.50 ppm (17), it 
is formed in a ratio of 4:1 (N9:N7). Phosphonate 17 was isolated as a colourless solid (1.34 g, 5 mmol, 
16%) after column chromatography (Rf (19) = 0.22; Gradient 0–10% MeOH in CH2Cl2).  
Melting point (MeOH): > 250 °C. 
1H NMR (400 MHz, DMSO-d6): 1.12 (6H, t, J = 7.04 Hz, OCH2CH3 x 2), 3.79-3.92 (6H, m, containing 
OCH2CH3 x 2 and OCH2P), 3.96 (2H, t, J = 4.61 Hz, ArCH2CH2O), 4.50 (2H, t, J = 4.61 Hz, ArCH2CH2O) 7.78 
(1H, s, ArC(2)H), 7.88 (bs, one of NH2), 7.93 (bs, one of NH2), 8.17 (1H, s, ArC(8)H). 
13C NMR (100 MHz, 
DMSO-d6): 16.13 (d, J = 5.56 Hz, OCH2CH3), 48.56 (ArCH2CH3O), 61.65 (d, J = 6.72 Hz, OCH2CH3), 63.72 (d, 
J = 162.03 Hz, OCH2P), 69.13 (d, J = 11.61 Hz, ArCH2CH2O), 120.36 (ArC(5)), 143.75 (ArC(8)H), 149.48 
(ArC(4)), 152.34 (ArC(2)H), 155.00 (ArC(6)). 31P NMR (175 MHz, DMSO-d6): 20.79 IR (KBr, cm
-1): 3382, 
3322, 2980, 2912, 1385, 1357, 1326, 1305, 1246, 1072. HRMS (ESI+): Exact mass calc. for C12H20N5O4P
+ 
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[M+H]+ = 330.1331; Found 330.1328. Anal. Calc.: C, 43.77; H, 6.12; N, 21.27; Found C, 44.08; H, 6.23; N, 
21.47. 
General procedure: Determination of the regioselectivity of the alkylation of adenine with 14 
To a stirred solution of iodide 14 (330 mg, 1.05 mmol, 1.05 equiv) in N,N-dimethylformamide (10 mL) 
was added adenine (135 mg, 1.00 mmol, 1.00 equiv) and the base (1.50 mmol, 1.50 equiv). The reaction 
mixture was stirred at room temperature or heated/cooled to the required temperature for 30 hours. 
The reaction mixture was filtered by gravity and the filtrate was concentrated in vacuo to yield a yellow 
oily residue which was then codistilled with toluene (3 × 20 mL) to remove the remaining traces of DMF. 
The crude reaction mixture was then analysed by 1H and 31P NMR. Based on integration of the NCH2 
signals in the 1H NMR spectrum of the crude reaction mixture at 4.33 ppm (6) and 4.50 ppm (20) the 
ratio of the two regioisomers was determined. 
Salt 21 
To a stirred suspension of adenine (3, 1.38 g, 10 mmol, 1.00 equiv) in dichloromethane (30 mL) was 
added aqueous tetrabutylammonium hydroxide (6.48 g of 1.51 M solution, equivalent to 2.59 g 
tetrabutylammonium hydroxide in 3.89 g water, 10 mmol, 1.00 equiv). The resulting cloudy mixture was 
allowed to stir for 20 minutes. Removal of the solvent in vacuo afforded an off-white residue which was 
azeotropically dried with toluene to afford the title compound as an off-white powder (3.76 g, 10 mmol, 
100%).  
Melting point (Toluene): 163-167 °C 
1H NMR (400 MHz, CDCl3): 0.92 (12H, t, J = 7.11 Hz, NCH2CH2CH2CH3), 1.21-1.38 (24H, m, containing 
NCH2CH2CH2CH3 and NCH2CH2CH2CH3), 2.92 (8H, m, NCH2CH2CH2CH3), 7.30 (2H, s, ArNH2), 7.91 (1H, s, 
ArC(8)H), 8.19 (1H, s, ArC(2)H). 13C NMR (100 MHz, CDCl3): 13.61 (NCH2CH2CH2CH3), 19.57 
(NCH2CH2CH2CH3), 23.80 (NCH2CH2CH2CH3), 58.40 (NCH2CH2CH2CH3), 118.12 (ArC(5)), 149.67 (ArC(8)H), 
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149.98 (ArC(4)), 153.27 (ArC(2)H), 160.57 (ArC(6)). IR (ATR, cm-1): 3340, 3240, 2958, 2873, 1626, 1590, 
1526, 1473, 1372, 1189, 1066, 879, 803, 701, 658, 581, 546. Elemental analysis: 20 requires C (66.98%), 
H (10.71%) N (22.32%); Found = C (67.31%), H (10.99%) and N (22.04%).  
Preparation of 6 via alkylation of salt 21 with iodide 14 
To a stirred solution of 21 (376 mg, 1.00 mmol, 1.00 equiv) in acetonitrile (10 mL) was added iodide 14 
(332 mg, 1.00 mmol, 1.00 equiv) in a single portion. The resulting solution was stirred at room 
temperature for 30 hours after which time the solvent was removed in vacuo. The resulting yellow 
residue was purified by column chromatography (0–10% MeOH in DCM) affording compound 6 as a 
colourless solid (211 mg, 0.68 mmol, 68%). 
Spectroscopic data for 6 were consistent with those reported above. 
Synthesis of O,O-diethyl ((2-(6-chloro-9H-purin-9-yl)ethoxy)methyl)phosphonate (24) and O,O-diethyl 
((2-(6-chloro-7H-purin-7-yl)ethoxy)methyl)phosphonate (23) from iodide 14. 
To a stirred solution of iodide 14 (177 mg, 0.55 mmol, 1.05 equiv) in DMF (1 mL) was added 6-
chloropurine (22, 77 mg, 0.50 mmol, 1.00 equiv) and potassium carbonate (100 mg, 0.75 mmol, 1.50 
equiv) in a single portion. The reaction was allowed to stir at room temperature for 24 hours until 
complete consumption of 19 was evident by TLC (Rf = 0.00; 10% MeOH in CH2Cl2). The reaction mixture 
was filtered by gravity and the filtrate was concentrated in vacuo to yield a yellow oily residue which 
was then co-distilled with toluene (3 × 30 mL) to remove the remaining traces of DMF. Purification by 
column chromatography afforded 23 and 24. 
Major product 24  
Isolated as the less polar product fraction (Rf = 0.41; 10% MeOH in DCM) (118 mg, 0.34 mmol, 68%) as a 
colourless foam.  
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1H NMR (400 MHz, DMSO-d6): 1.11 (6H, t, J = 7.10 Hz, OCH2CH3 x 2), 3.85-3.96 (8H, m, containing OCH2P, 
OCH2CH3 x 2, ArCH2CH2O), 4.51 (2H, t, J = 4.90 Hz, ArCH2CH2O), 8.67 (1H, s, ArC(8)H), 8.80 (1H, s, 
ArC(2)H). 13C NMR (100 MHz, DMSO-d6): 16.07 (d, J = 5.74 Hz, OCH2CH3), 43.27 (ArCH2CH2O), 61.59 (d, J 
= 6.30 Hz, OCH2CH3), 63.61 (d, J = 161.53 Hz, OCH2P), 69.80 (d, J = 11.31 Hz, ArCH2CH2O), 130.67 (ArC(5)), 
147.70 (ArC(8)H), 148.88 (ArC(4)), 151.45 (ArC(2)H), 151.96 (ArC(6)). 31P NMR (175 MHz, DMSO-d6): 
20.88. IR (ATR, cm-1): 2984, 2907, 1633, 1590, 1562, 1425, 1395, 1335, 1240, 1121, 1025, 971, 875, 830, 
857, 637, 475. HRMS (ESI+): Exact mass calc. for C12H19ClN4O4P
+ [M+H]+ = 349.0827; Found = 349.0811.  
Minor product 23:  
Isolated as the more polar product fraction (Rf = 0.36; 10% MeOH in DCM) (15 mg, 0.045 mmol, 9%) as a 
colourless foam.  
1H NMR (400 MHz, DMSO-d6): 1.10 (6H, t, J = 7.04 Hz, OCH2CH3 x 2), 3.70-3.95 (8H, m, containing OCH2P, 
OCH2CH3 x 2, ArCH2CH2O), 4.69 (2H, t, J = 5.00 Hz, ArCH2CH2O), 8.75 (1H, s, ArC(8)H), 8.81 (1H, s, 
ArC(2)H). 13C NMR (100 MHz, DMSO-d6): 16.11 (d, J = 5.72 Hz, OCH2CH3), 46.14 (ArCH2CH2O), 61.55 (d, J 
= 6.19 Hz, OCH2CH3), 63.74 (d, J = 159.73 Hz, OCH2P), 70.84 (d, J = 10.59 Hz, ArCH2CH2O), 122.03 (ArC(5)), 
142.19 (ArC(4)), 151.38 (ArCH), 151.46 (ArCH), 161.58 (ArC(6)). 31P (175 MHz, DMSO-d6): 20.91. IR (ATR, 
cm-1): 2982, 2929, 1634, 1587, 1564, 1544, 1454, 1422, 1392, 1355, 1236, 1122, 1049, 1025, 97, 829, 
643, 466. HRMS (ESI+): Exact mass calc. for C12H19ClN4O4P
+ [M+H]+ = 349.0827; Found = 349.0815. 
Synthesis of N9-[2-(diethoxyphosphorylmethoxy)ethyl]adenine (6) from O,O-diethyl ((2-(6-chloro-9H-
purin-9-yl)ethoxy)methyl)phosphonate (24) 
A stirred solution of phosphonate 24 (100 mg, 0.28 mmol, 1.00 equiv) in 7 M methanolic ammonia (1 
mL) was heated to reflux for six hours after which time, the starting material was no longer evident by 
TLC (Rf = 0.41; 10% MeOH in DCM). Removal of the solvent in vacuo yielded a yellow residue which was 
purified by column chromatography to give 6 as a colourless solid (75 mg, 0.23 mmol, 81%). 
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Synthesis of O,O-diethyl ((2-(6-(benzylamino)-9H-purin-9-yl)ethoxy)methyl)phosphonate (27) and O,O-
diethyl ((2-(6-(benzylamino)-7H-purin-9-yl)ethoxy)methyl)phosphonate (26) from iodide 14.  
To a stirred solution of iodide 14 (177 mg, 0.55 mmol, 1.05 equiv) in DMF (1 mL) was added N6-
benzyladenine (25) [6] (112 mg, 0.50 mmol, 1.00 equiv) and potassium carbonate (100 mg, 0.75 mmol, 
1.50 equiv) in a single portion. The reaction was allowed to stir at room temperature for 24 hours until 
complete consumption of 25 was evident by TLC (Rf = 0.19, 10% MeOH in CH2Cl2). The reaction mixture 
was filtered by gravity and the filtrate was concentrated in vacuo to yield a yellow oily residue which 
was then co-distilled with toluene (3 × 30 mL) to remove the remaining traces of DMF. Purification by 
column chromatography (0–10% MeOH in DCM) afforded 26 and 27. 
Major product 27: 
Isolated as the less polar product following column chromatography (147 mg, 35 mmol,  70%) 
1H NMR (400 MHz, DMSO-d6): 1.12 (6H, t, J = 6.91 Hz, OCH2CH3 x 2), 3.84-3.93 (8H, m, containing 
ArCH2CH2O, OCH2P and OCH2CH3 x 2), 4.35 (2H, t, J = 4.80 Hz, ArCH2CH2O), 4.70 (2H, bs, NHCH2Ph), 7.20 
(2H, t, J = 7.37 Hz, m-ArCH x 2), 7.26-7.35 (3H, m, containing o-ArCH x 2 and p-ArCH), 8.12 ppm (1H, s, 
ArC(8)H), 8.20 (1H, s, ArC(2)H), 8.35 (1H, bs, NHCH2Ph).
13C NMR (100 MHz, DMSO-d6): 16.16 (d, J = 5.71 
Hz, OCH2CH3), 42.36 (ArCH2CH2O), 42.78 (NHCH2Ph), 61.64 (d, J = 6.25 Hz, OCH2CH3), 63.64 (d, J = 164.62 
Hz, OCH2P), 70.27 (d, J = 12.00 Hz, ArCH2CH2O), 118.88 (ArC(5)), 126.52 (p-ArCH), 127.06 (m-ArCH), 
128.12 (o-ArCH), 140.46 (ArC(4)), 140.99 (ArC(8)H), 148.89 (ArC(2)H), 152.26 (ArC(6)), 154.28 (i-ArC). 31P 
NMR (175 MHz, DMSO-d6): 21.38. IR (ATR, cm
-1): 3278, 2982, 2915, 1617, 1581, 1482, 1452, 1243, 1120, 
1026, 970, 648. HRMS (ESI+): Exact mass calc. for C19H27N5O4P
+ = 420.1795; Found = 420.1799.  
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Minor product 26: 
Isolated as the more polar product following column chromatography (6 mg, 0.015 mmol, 3%). Due to 
restricted rotation, two rotameric forms are observable by 1H NMR in a ratio of 0.3:0.7 – designated as 
minor and major respectively. 
1H NMR (600 MHz, DMSO-d6): 1.07-1.11 (6H, m, overlapping OCH2CH3  x 2 (major) and OCH2CH3 x 2 
(minor)), 3.82-3.87 (4H, m, overlapping OCH2CH3 x 2(major) and OCH2CH3 x 2(minor)), 3.95-3.98 (2H, m, 
overlapping ArCH2CH2O (major) and ArCH2CH2O (minor)), 4.48-4.51 (2H, m overlapping ArCH2CH2O 
(major) and ArCH2CH2O (minor)), 4.75 (bs, NHCH2Ph (major)), 5.32 (d, J = 7.17 Hz, NHCH2Ph (minor)), 
7.22 (1H, t, J = 7.25 Hz, overlapping p-ArCH (major) and (minor)), 7.30 (2H, t, J = 7.80 Hz, overlapping m-
ArCH (major) and (minor)), 7.35 (d, J = 7.80 Hz, o-ArCH (major)), 7.38 (d, J = 7.48 Hz, o-ArCH (minor)), 
7.78 (1H, s, ArC(2)H (major) and (minor)), 8.23 (1H, s, ArC(8)H (minor)), 8.33 (1H. s. ArC(8)H (major)), 
8.73 (t, J = 7.17 Hz, NHCH2Ph (minor)), 8.98 (1H, bs, NHCH2Ph (major)). 
13C NMR (125 MHz, DMSO-d6): 
16.52 (d, J = 5.08 Hz, OCH2CH3 (major) and (minor)), 45.83 (ArCH2CH2O (major)), 46.06 (ArCH2CH2O 
(minor)), 48.95 (NHCH2Ph (minor)), 49.16 (NHCH2Ph (major)), 62.16 (d, J = 6.32 Hz, OCH2CH3 (major) and 
(minor)), 64.26 (d, J = 162.03 Hz, OCH2P (major) and (minor)) 69.61 (d, J = 11.85 Hz, ArCH2CH2O (major) 
and (minor)), 121.48 (ArC (major)), 127.25 (ArC (minor)), 127.65 (ArC (major)), 127.84 (ArC (minor)), 
128.35 (ArC (major)), 128.56 (ArC (minor)), 128.72 (ArC (major) and (minor)), 139.97 (ArC (major)), 
140.32 (ArC (minor)), 143.88 (ArC (major)), 144.35 (ArC (minor)), 149.36 (ArC (major)), 151.29 (ArC 
(minor)), 152.75 (ArC (major)), 152.94 (ArC (minor)), 153.66 (ArC (major)), 154.21 (ArC (minor)). 31P NMR 
(225 MHz, DMSO-d6): 21.74. IR (ATR, cm
-1): 3278, 2982, 2915, 1617, 1581, 1482, 1452, 1243, 1120, 1026, 
970, 648. HRMS (ESI+): Exact mass calc. for C19H27N5O4P
+ [M+H]+ = 420.1795; Found = 420.1798.  
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Synthesis of N9-[2-(diethoxyphosphorylmethoxy)ethyl]adenine (6) from O,O-diethyl ((2-(6-
(benzylamino)-9H-purin-9-yl)ethoxy)methyl)phosphonate (27)  
Phosphonate 27 (105 mg, 0.25 mmol, 1.00 equiv), 5% Pd/C (10 mg) and a magnetic stirring bar were 
added to a 25 mL round-bottomed flask. The flask was evacuated a refilled three times with hydrogen 
from a latex balloon before ethanol (3 mL) was added. The resulting black suspension was stirred at 
room temperature for 24 hours before being filtered through a pad of Celite© and concentrated in 
vacuo. The resulting colourless solid was purified by column chromatography giving 6 as a colourless 
solid (72 mg, 0.22 mmol, 89%). 
Synthesis of O,O-diethyl ((2-(6-(((dimethylamino)methylene)amino)-7H-purin-7-
yl)ethoxy)methyl)phosphonate (29) 
To a stirred solution of iodide 14 (177 mg, 0.55 mmol, 1.05 equiv) in DMF (1 mL) was added purine [7] 
28 (95 mg, 0.50 mmol, 1.00 equiv) and potassium carbonate (100 mg, 0.75 mmol, 1.50 equiv) in a single 
portion. The reaction was allowed to stir at room temperature for 24 hours until complete consumption 
of 28 was evident by TLC (Rf = 0.00, 10% MeOH in CH2Cl2). The reaction mixture was filtered by gravity 
and the filtrate was concentrated in vacuo to yield a yellow oily residue which was then co-distilled with 
toluene (3 × 30 mL) to remove the remaining traces of DMF. Purification by column chromatography (Rf 
= 0.44, 10% MeOH in DCM) afforded 29 (151 mg, 0.39 mmol, 79%) as a colourless solid. 
1H NMR (400 MHz, DMSO-d6): 1.12 (6H, t, J = 6.95 Hz, OCH2CH3 x 2), 3.08 (3H, s, one of N(CH3)2), 3.21 
(3H, s, one of N(CH3)2), 3.82-3.95 (8H, m, containing OCH2CH3 x 2, OCH2P and ArCH2CH2O), 4.68 (2H, t, J = 
4.72 Hz, ArCH2CH2O), 8.31 (1H, s, ArC(8)H), 8.42 (1H, s, ArC(2)H), 8.90 (1H, s, N=C-H). 
13C NMR (100 MHz, 
DMSO-d6): 16.13 (d, J = OCH2CH3), 34.67 (one of N(CH3)2), 40.64 (one of N(CH3)2), 46.12 (ArCH2CH2O), 
61.63 (d, J  = 6.29 Hz, OCH2CH3), 63.64 (d, J = 162.75 Hz, OCH2P), 71.52 (d, J = 11.52 Hz, ArCH2CH2O), 
116.55 (ArC(5)), 147.11 (ArC(8)H), 151.76 (ArC(2)H), 154.49 (ArC(4)), 156.46 (N=C-H), 160.79 (ArC(6)). 31P 
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(175 MHz, DMSO-d6): 20.92. IR (ATR, cm
-1): 2983, 2930, 1633, 1584, 1563, 1543, 1498, 1454, 1421, 1353, 
1235, 1118, 1047, 1022, 970, 874, 807, 637, 622. HRMS (ESI+): Exact mass calc. for C15H26N6O4P
+ [M+H]+ = 
385.1748; Found = 385.1755.  
Synthesis of 2-chloroethoxymethylphosphonic acid (31) 
To a stirred solution of phosphonate ester 19 (5.52 g, 24 mmol, 1.00 equiv) in acetonitrile (110 mL) was 
added trimethylsilyl bromide (15.10 g, 96 mmol, 4.00 equiv) in a single portion. The reaction was stirred 
under a blanket of nitrogen overnight, after which time the solution became pale brown. The reaction 
mixture was then concentrated in vacuo and co-distillation with acetonitrile (50 mL) and methanol (4 × 
30 mL) furnished the title compound (4.18 g, 24 mmol, 100%) as a colourless oil, which was used 
without further purification. Note the colourless oil developed a slight brown colour on standing. 
1H NMR (400 MHz, DMSO-d6): 3.60 (2H, d, J = 8.59 Hz, OCH2P), 3.72-3.81 (4H, m, containing ClCH2CH2O 
and ClCH2CH2O). 
13C NMR (100 MHz, DMSO-d6): 43.15 (ClCH2CH2O), 66.28 (d, J = 160.87 Hz, OCH2P), 
72.09 (d, J = 10.59 Hz, ClCH2CH2O). 
31P NMR (175 MHz, DMSO-d6): 16.60. IR (ATR, cm
-1): 3388, 2885, 
2300, 1634, 1113, 1005, 945, 666, 527. HRMS (ESI-): Exact mass calc. for C3H7ClO4P
-[M-H]- = 172.9776; 
Found = 172.9743. 
Synthesis of iodomethyl pivalate (32) 
To a stirred solution of chloromethyl pivalate (2.50 g, 17 mmol, 1.00 equiv) in acetonitrile (5 mL) was 
added sodium iodide (4.50 g, 30 mmol, 1.90 equiv) in a single portion. The reaction mixture was allowed 
to stir under a nitrogen atmosphere overnight at 30 °C, during which time a strong brown colour had 
formed. Reaction progress was followed by 1H NMR by taking aliquots from the reaction and removing 
the solvent in vacuo. Dichloromethane (25 mL) and water (25 mL) were subsequently added to the 
reaction mixture. The dichloromethane layer was separated from the aqueous layer and then washed 
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with 2% sodium thiosulfate solution (20 mL) before drying over anhydrous magnesium sulfate. Removal 
of the solvent in vacuo afforded the title compound as a yellow-pink oil (3.46 g, 14.5 mmol, 85%).  
Spectroscopic data were consistent with those reported previously in the literature [8]  
1H NMR (300 MHz, CDCl3): 1.19 (9H, s, C(CH3)3), 5.93 (2H, s, OCH2I). 
13C NMR (75 MHz, CDCl3): 26.74 
(C(CH3)3), 31.37 (OCH2I), 38.9 (C(CH3)3), 176.27 (C=O). 
Synthesis of O,O-di(pivaloxymethyl) 2-chloroethoxymethylphosphonate (33) 
To a stirred solution of phosphonic acid 31 (860 mg, 5.00 mmol, 1.00 equiv) in acetonitrile (50 mL) was 
added DBU (1.90 g, 12.50 mmol, 2.50 equiv) in a single portion. The resulting solution was stirred at 
room temperature for 30 minutes. Pivalate 32 (3.02 g, 12.50 mmol, 2.50 equiv) was then added and the 
resulting solution was stirred for 48 h at room temperature. Removal of the solvent in vacuo afforded a 
yellow residue which was purified by column chromatography (eluent: 100% diethyl ether) giving the 
title compound as a yellow oil (1.08 g, 2.7 mmol, 54%). 
1H NMR (400 MHz, CDCl3): 1.24 (18H, s, 2 x C(CH3)3), 3.63 (2H, t, J = 6.98 Hz, ClCH2CH2O), 3.86 (2H, t, J = 
6.98 Hz, ClCH2CH2O), 3.95 (2H, d, J = 8.99 Hz, OCH2P), 5.69-5.75 (4H, m, OCH2O). 
13C NMR (100 MHz, 
CDCl3): 26.81 (C(CH3)3). 38.71 (ClCH2CH2O), 42.27 (C(CH3)3), 65.53 (d, J = 165.61 Hz, OCH2P), 73.11 (d, J = 
9.63 Hz, ClCH2CH2O), 81.69 (d, J = 6.31 Hz, OCH2O), 176.80 (C=O). 
31P NMR (175 MHz, CDCl3): 20.70. IR 
(ATR, cm-1): 2974, 2936, 2912, 2875, 1750, 1481, 1462, 1429, 1275, 1130, 1055, 998, 958, 890, 767, 564. 
HRMS (ESI+): Exact mass calc. for C15H29ClNO8P
+ [M+H]+ = 403.1283; Found = 403.1289. 
((2-Oxido-1,4,2-dioxaphosphinan-2-yl)oxy)methyl pivalate (35) 
To a stirred solution of phosphonate 33 (201 mg, 0.50 mmol, 1.00 equiv) in MeCN (5 mL) in a microwave 
vial was added DBU (153 mg, 1.00 mmol, 2.00 equiv) and a magnetic stirrer bar. The vial was sealed with 
a Teflon cap and heated with stirring to 120 °C in a CEM Discovery SP Microwave Synthesizer. The 
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reaction mixture was held at this temperature for 20 minutes and then allowed to cool gradually. The 
contents were then diluted with DCM (20 mL) and washed with 2 M HCl (2 × 10 mL) and brine (1 × 10 
mL) before being dried over magnesium sulfate and concentrated in vacuo affording the title compound 
as a pale yellow oil (110 mg, 0.44 mmol, 88%). 
1H NMR (400 MHz, CDCl3): 1.25 (9H, s, C(CH3)3), 3.70-3.74 (1H, m, one of C(6)H), 3.80-3.83 (1H, m, one of 
C(6)H), 3.95 (1H, d, J = 14.74 Hz, one of C(2)H), 4.11-4.17 (1H, m one of C(2)H), 4.30-4.38 (1H, m, one of 
C(5)H), 4.52-4.58 (1H, m, one of C(5)H), 5.70-5.78 (2H, m, OCH2O). 
13C NMR (100 MHz, CDCl3): 26.85 
(C(CH3)3), 38.77 (C(CH3)3), 65.09 (d, J = 145.73 Hz, C(4)), 66.62 (d, J = 6.36 Hz, C(5)), 71.44 (d, J = 8.86 Hz, 
C(6)H), 81.45 (d, J = 6.05 Hz, OCH2O), 176.57 (C=O). 
31P NMR (175 MHz, CDCl3): 11.75. IR (ATR, cm
-1): 
2972, 2932, 2873, 1748, 1691, 1611, 1481, 1256, 1135, 1120, 1094, 1049, 989, 931, 852, 593. HRMS 
(ESI+): Exact mass calc. for C9H18O6P
+ [M+H]+ = 253.0836; Found = 253.0839. 
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